Literature DB >> 11432823

Scrapie strains maintain biological phenotypes on propagation in a cell line in culture.

C R Birkett1, R M Hennion, D A Bembridge, M C Clarke, A Chree, M E Bruce, C J Bostock.   

Abstract

Bovine spongiform encephalopathy (BSE) and its human equivalent, variant Creutzfeldt-Jakob disease (vCJD), are caused by the same strain of infectious agent, which is similar to, but distinct from, >20 strains of their sheep scrapie homologue. A better understanding of the molecular strain determinants could be obtained from cells in monoculture than from whole animal studies where different cell targeting is commonly a strain-related feature. Although a few cell types can be infected with different strains, the phenotypes of the emergent strains have not been studied. We have cured the scrapie-infected, clonal SMB cell line with pentosan sulfate, stably re-infected it with a different strain of scrapie and shown that biological properties and prion protein profiles characteristic of each original strain are propagated faithfully in this single non-neuronal cell type. These findings attest to the fact that scrapie strain determinants are stable and host-independent in isolated cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432823      PMCID: PMC125505          DOI: 10.1093/emboj/20.13.3351

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Multiplication of the scrapie agent.

Authors:  D A Haig; M C Clarke
Journal:  Nature       Date:  1971-11-12       Impact factor: 49.962

6.  Evidence for the multiplication of scrapie agent in cell culture.

Authors:  M C Clarke; D A Haig
Journal:  Nature       Date:  1970-01-03       Impact factor: 49.962

7.  Chemoprophylaxis of scrapie in mice.

Authors:  H Diringer; B Ehlers
Journal:  J Gen Virol       Date:  1991-02       Impact factor: 3.891

8.  Truncated forms of the human prion protein in normal brain and in prion diseases.

Authors:  S G Chen; D B Teplow; P Parchi; J K Teller; P Gambetti; L Autilio-Gambetti
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

9.  Synthesis and trafficking of prion proteins in cultured cells.

Authors:  A Taraboulos; A J Raeber; D R Borchelt; D Serban; S B Prusiner
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

10.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.

Authors:  D A Butler; M R Scott; J M Bockman; D R Borchelt; A Taraboulos; K K Hsiao; D T Kingsbury; S B Prusiner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  53 in total

Review 1.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

2.  Low density subcellular fractions enhance disease-specific prion protein misfolding.

Authors:  James F Graham; Sonya Agarwal; Dominic Kurian; Louise Kirby; Teresa J T Pinheiro; Andrew C Gill
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

3.  CRBL cells: establishment, characterization and susceptibility to prion infection.

Authors:  Charles E Mays; Hae-Eun Kang; Younghwan Kim; Sung Han Shim; Ji-Eun Bang; Hee-Jong Woo; Youl-Hee Cho; Jae-Beom Kim; Chongsuk Ryou
Journal:  Brain Res       Date:  2008-03-18       Impact factor: 3.252

4.  Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.

Authors:  Ryuichiro Atarashi; Valerie L Sim; Noriyuki Nishida; Byron Caughey; Shigeru Katamine
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Aberrant Alterations of Mitochondrial Factors Drp1 and Opa1 in the Brains of Scrapie Experiment Rodents.

Authors:  Xiao -Dong Yang; Qi Shi; Jing Sun; Yan Lv; Yue Ma; Cao Chen; Kang Xiao; Wei Zhou; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2016-12-06       Impact factor: 3.444

6.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Engineering a murine cell line for the stable propagation of hamster prions.

Authors:  Matthew E C Bourkas; Hamza Arshad; Zaid A M Al-Azzawi; Ondrej Halgas; Ronald A Shikiya; Mohadeseh Mehrabian; Gerold Schmitt-Ulms; Jason C Bartz; Joel C Watts
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

8.  Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.

Authors:  Yuzuru Taguchi; Zhen-Dan Shi; Brian Ruddy; David W Dorward; Lois Greene; Gerald S Baron
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

9.  Manganese enhances prion protein survival in model soils and increases prion infectivity to cells.

Authors:  Paul Davies; David R Brown
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

10.  Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Authors:  Clive Bate; Mourad Tayebi; Luisa Diomede; Mario Salmona; Alun Williams
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.